Berberine — The AMPK Activator
Berberine is an alkaloid found in goldenseal, barberry, and Oregon grape. It activates AMPK (the cellular energy sensor) and has demonstrated effects comparable to metformin in multiple human trials for blood glucose regulation, lipid metabolism, and gut microbiome modulation.
Mechanism of Action
Berberine inhibits Complex I of the mitochondrial electron transport chain, which reduces ATP/ADP ratio and activates AMPK. AMPK activation suppresses mTOR, activates autophagy, improves insulin sensitivity, and reduces hepatic glucose production. Berberine also modulates the gut microbiome, increasing Akkermansia muciniphila.
Human Trial Evidence
A 2008 Metabolism RCT (Yin et al.) showed 500 mg TID berberine was as effective as metformin for blood glucose control in type 2 diabetics over 3 months. Multiple meta-analyses confirm significant reductions in HbA1c (−0.9%), fasting glucose (−1.1 mmol/L), and LDL cholesterol (−0.65 mmol/L).
Dosing Protocol
500 mg 2–3× daily with meals (total 1,000–1,500 mg/day). Take with food to reduce GI side effects. Dihydroberberine (DHB) has ~5× better bioavailability and is better tolerated. Cycle 8 weeks on, 2–4 weeks off to prevent tolerance.
Safety & Contraindications
Common GI side effects: nausea, diarrhea, constipation (especially at initiation). Berberine inhibits CYP3A4, CYP2D6 — significant drug interactions with cyclosporine, statins, and metformin (additive hypoglycemia risk). Contraindicated in pregnancy (uterotonic effects). Monitor blood glucose if diabetic.